How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? ; volume:9 ; number:1 ; day:12 ; month:4 ; year:2016 ; pages:1-12 ; date:12.2016
Journal of hematology & oncology ; 9, Heft 1 (12.4.2016), 1-12, 12.2016
- Creator
-
Chang, Ying-Jun
- Contributor
-
Luznik, Leo
Fuchs, Ephraim J.
Huang, Xiao-Jun
SpringerLink (Online service)
- DOI
-
10.1186/s13045-016-0265-2
- URN
-
urn:nbn:de:1111-2016041315682
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chang, Ying-Jun
- Luznik, Leo
- Fuchs, Ephraim J.
- Huang, Xiao-Jun
- SpringerLink (Online service)
Other Objects (12)
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients
Distinct Immune Homeostasis Remodeling Patterns after HLA‐Matched and Haploidentical Transplantation
Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation
Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation
Immunological implications of feto-maternal microchimerism in HLA-haploidentical stem cell transplantation : Immunologische Auswirkungen eines fetomaternalen Mikrochimärismus auf die pädiatrische HLA-haploidente Stammzelltransplantation
T-cell-replete HLA-haploidentical transplantation using post-transplantation high-dose cyclophosphamide in high risk and advanced ALL: feasibility and early outcome
Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
Intra‐arterial transplantation of HLA ‐matched donor mesoangioblasts in Duchenne muscular dystrophy
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants
Donor-cell leukemia with novel genetic features 2 years after sex-mismatched T cell-depleted haploidentical stem cell transplantation
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients
Distinct Immune Homeostasis Remodeling Patterns after HLA‐Matched and Haploidentical Transplantation
Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation
Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation
Immunological implications of feto-maternal microchimerism in HLA-haploidentical stem cell transplantation : Immunologische Auswirkungen eines fetomaternalen Mikrochimärismus auf die pädiatrische HLA-haploidente Stammzelltransplantation
T-cell-replete HLA-haploidentical transplantation using post-transplantation high-dose cyclophosphamide in high risk and advanced ALL: feasibility and early outcome
Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
Intra‐arterial transplantation of HLA ‐matched donor mesoangioblasts in Duchenne muscular dystrophy
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants
Donor-cell leukemia with novel genetic features 2 years after sex-mismatched T cell-depleted haploidentical stem cell transplantation
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients
Distinct Immune Homeostasis Remodeling Patterns after HLA‐Matched and Haploidentical Transplantation
Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation
Long-term survivors demonstrate superior quality of life after haploidentical stem cell transplantation to matched sibling donor transplantation
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation
Immunological implications of feto-maternal microchimerism in HLA-haploidentical stem cell transplantation : Immunologische Auswirkungen eines fetomaternalen Mikrochimärismus auf die pädiatrische HLA-haploidente Stammzelltransplantation
T-cell-replete HLA-haploidentical transplantation using post-transplantation high-dose cyclophosphamide in high risk and advanced ALL: feasibility and early outcome
Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
Intra‐arterial transplantation of HLA ‐matched donor mesoangioblasts in Duchenne muscular dystrophy
Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants